9 unchanged sentences
On November 20, 2019, we filed our answer to the complaint, denying infringement and seeking a declaratory judgement of invalidity of the ‘441 Patent.
−Removed: On June 22, 2020, we filed a petition requesting institution of an inter-partes review ("IPR") to the Patent Trial and Appeals Board (the “Board”) at the United States Patent Office requesting the Board to find a set of claims in the ‘441 Patent invalid.
+Added: On June 22, 2020, we filed a petition requesting institution of an inter-partes review ("IPR") to the Patent Trial and Appeals Board (the “Board”) at the United States Patent Office requesting the Board to find a set of claims in the ‘441 Patent invalid.
On June 27, 2020, we filed a second petition requesting institution of an IPR requesting the Board to find another set of claims in the ‘441 Patent invalid.
4 unchanged sentences
In the second IPR, the Board did not find the disputed claims unpatentable.
−Removed: We are appealing the decision in the second IPR to the U.S.
−Removed: Court of Appeals for the Federal Circuit.
+Added: We appealed the decision in the second IPR to the U.S.
+Added: Court of Appeals for the Federal Circuit, which held a hearing on December 7, 2023.
+Added: On January 9, 2024, the U.S.
+Added: Court of Appeals for the Federal Circuit affirmed the decisions of the Board.
On August 19, 2020, the court ordered a stay of the PGI District Court matter based on a joint stipulation by the parties pending a final written decision on the IPRs.
4 unchanged sentences
In December 2022, Take2 Technologies, Ltd.
−Removed: and the Chinese University of Hong Kong filed a complaint in the U.S.
+Added: (“Take2”) and the Chinese University of Hong Kong filed a complaint in the U.S.
District Court for Delaware against us alleging infringement of U.S.
1 unchanged sentence
22- cv-01595).
−Removed: The complaint alleges that our Sequel® II systems, Sequel IIe Systems, and Revio™ Systems that operate version 11.0 or later of the SMRT® Link software, infringe the ‘794 Patent.
+Added: The complaint alleges that our Sequel TM II systems, Sequel IIe Systems, and Revio TM Systems that operate version 11.0 or later of the SMRT TM Link software, infringe the ‘794 Patent.
The complaint seeks unspecified monetary damages and an order enjoining us from infringing the ’794 Patent.
−Removed: We filed a motion to dismiss on February 14, 2023.
We believe the infringement allegations in the complaint lack merit and we intend to vigorously defend in this matter.
+Added: We filed a motion to dismiss on February 14, 2023.
+Added: We also filed a motion to transfer the case to the Northern District of California which was granted on August 2, 2023 and the case was transferred on August 16, 2023 (C.A.
+Added: 5:23-cv-04166).
+Added: A hearing occurred on February 22, 2024 on the motion to dismiss the case and the motion was taken under submission for future decision.
+Added: Take2 filed a motion to disqualify our in-house legal department from representing PacBio in the district court action on September 20, 2023.
+Added: We opposed Take2’s disqualification motion on October 4, 2023.
+Added: An oral hearing on the disqualification motion was held on October 26, 2023 and the court issued orders November 6 and December 4 of 2023 partially granting the motion.
+Added: While some members of the in-house legal department were disqualified, General Counsel for PacBio was not disqualified and continues to represent PacBio in the district court action.
+Added: On October 17, 2023, we filed a petition requesting institution of an IPR requesting the Board to find all claims of the ’794 patent invalid.
+Added: We anticipate a decision by the United States Patent and Trademark Office on whether to institute a trial on the validity of the claims of the '794 patent on or before April 26, 2024.
Proceedings in China
17 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.